Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Filippo de Marinis"'
Autor:
Salvatore Intagliata, Serena Ricciardi, Alberto Fulvi, Bruno Gori, Ester Del Signore, Filippo de Marinis
Publikováno v:
Therapeutics and Clinical Risk Management
Lung cancer is the leading cause of mortality worldwide. Non-small cell lung cancer (NSCLC) is a particularly aggressive cancer, the optimum management of which is still being determined. In the metastatic disease, the standard therapy is a platinum-
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2009, Iss default, Pp 781-787 (2009)
Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management
Serena Ricciardi1, Silverio Tomao2, Filippo de Marinis11Thoracic-Oncology Unit 1st, Lung Diseases Department, San Camillo-Forlanini High Specialization Hospitals, Rome, Italy; 2Sperimental Medicine Department, Rome, ItalyAbstract: Pemetrexed is a new